USD 10.2 billion
Report ID:
SQMIG35D2214 |
Region:
Global |
Published Date: March, 2025
Pages:
219
|Tables:
99
|Figures:
76
Peripheral Interventions Market size was valued at USD 10.2 billion in 2023 and is poised to grow from USD 11.13 billion in 2024 to USD 22.34 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).
The growing prevalence of cardiovascular disorders (CVD) is poised to be a significant motive force for the demand within the area of peripheral interventions. Factors which include high blood pressure, diabetes mellitus, obesity, smoking, and the consumption of carbohydrate-rich diets are contributing to the development of various sorts of CVD.
In response to this growing health subject, there's increasingly more catheterization laboratories (cath labs) internationally, in particular in rising markets. This growth is accompanied by an uptick within the range of healthcare specialists specializing in peripheral interventions, similarly fueling the growth of this industry.
Cath labs have ended up critical inside the analysis and treatment of cardiovascular conditions, and their adoption is on the rise, specifically in developing countries. Furthermore, the emergence of hybrid catheterization labs has been a noteworthy development in current years. These hybrid labs are versatile and are used now not handiest for cardiac peripheral interventions but also for vascular, neurological, electrophysiology, and various other clinical methods.
India, for example, has witnessed a tremendous increase within the range of cath labs, more than doubling nowadays. This expansion has been observed with the aid of a tremendous surge in peripheral intervention strategies. The upward push in angioplasties, a common remedy for CVD, is also contributing to improved healthcare spending globally. The boom within the number of experts that specialize in peripheral interventions and the establishment of catheterization laboratories are predicted to drive in addition enlargement within the industry, as the call for for these techniques maintain to grow.
Market snapshot - 2025-2032
Global Market Size
USD 10.2 billion
Largest Segment
Hospitals
Fastest Growth
Hospitals
Growth Rate
9.1% CAGR
To get more reports on the above market click here to Buy The Report
Global Peripheral Interventions Market is segmented by Intervention Type, Device Type, Indication, Technology, End User and region. Based on Intervention Type, the market is segmented into Atherectomy, Stent Implantation, Angioplasty, Thrombectomy and Embolization. Based on Device Type, the market is segmented into Catheters, Stents, Guide Wires, Balloons and Embolic Coils. Based on Indication, the market is segmented into Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis and Carotid Artery Stenosis. Based on Technology, the market is segmented into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy and Directional Atherectomy. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Within the global peripheral interventions market, one prominent application that typically commands a leading position is peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of arteries in the peripheral vascular system, often affecting the lower limbs, particularly the legs. This condition is pervasive and necessitates various peripheral interventions designed to enhance blood flow and alleviate associated symptoms.
While PAD continues to assert its dominance, another segment experiencing rapid growth is venous thromboembolism (VTE). VTE encompasses a spectrum of conditions, including deep vein thrombosis (DVT) and pulmonary embolism (PE), which involve the formation of blood clots within the venous system. The increasing demand for peripheral interventions related to VTE is driven by heightened awareness, improved diagnostic capabilities, and a growing population at risk of venous thromboembolic events.
In terms of end-use segments within the global peripheral interventions market, hospitals emerge as the dominant player. Hospitals serve as pivotal healthcare institutions where a wide spectrum of medical procedures, including peripheral interventions, are routinely carried out. Their expansive infrastructure, specialized medical departments, and the presence of highly skilled healthcare professionals collectively position hospitals as central contributors to this market. Their comprehensive capabilities and resources make them a cornerstone in the landscape of peripheral interventions.
Conversely, the segment experiencing the most rapid growth in the market is that of Ambulatory surgical centers (ASCs). These facilities provide a greater streamlined and convenient alternative for particular clinical approaches, including peripheral interventions. ASCs are favored by patients due to their shorter ready instances, decreased sanatorium remains, and personalized care. The increasing popularity and accessibility of ASCs in the healthcare surroundings have translated right into an excellent upsurge in the quantity of peripheral interventions performed inside those facilities.
To get detailed analysis on other segments, Request For Free Sample Report
North America has held a dominant role in the marketplace, commonly due to technological improvements, strong scientific repayment facilities, and a growing stage of consciousness of some of the populace in this location. With a rising prevalence of coronary artery sicknesses and a developing prevalence of peripheral vascular illnesses, North America is poised to preserve its marketplace leadership for the duration of the forecast length.
The Asia Pacific region is predicted to witness the very best increase by 2022, driven by means of its hastily growing economic system and increasing healthcare infrastructure. Increasing personal disposable profits, robust government help within the healthcare sector, and rising awareness of peripheral issues diagnostics are key factors propelling the peripheral interventional marketplace in this vicinity. In 2021, North America's peripheral interventions marketplace accounted for over 40% of the entire sales proportion. The presence of primary players within the location and a professional healthcare workforce make contributions to the market's sturdy demand. Prominent industry leaders like Johnson & Johnson, Medtronic, Becton Dickinson, and Boston Scientific Corporation have installed a sturdy presence in North America, specially inside the United States, in which healthcare professionals quite simply undertake modern merchandise, developing beneficial opportunities for enterprise gamers.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Cardiovascular Disease (CVD) Prevalence
Conscientization and early detection
Positive governmental actions
High Costs of Treatment
Remote Areas with Limited Access
Possible Complications
Request Free Customization of this report to help us to meet your business objectives.
The global peripheral interventions market presents a dynamic competitive scenario, marked by the active participation of numerous prominent companies seeking market leadership. Key industry players, including Johnson & Johnson, Medtronic, Becton Dickinson, and Boston Scientific Corporation, hold pivotal roles in shaping the landscape of this sector. These industry giants capitalize on their extensive expertise, robust research and development capabilities, and global market presence to introduce innovative solutions spanning various segments within peripheral interventions.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global peripheral interventions market analysis, The global peripheral interventions market is positioned for sustained growth and transformation, driven by a multitude of factors that are reshaping the healthcare landscape. The market is currently experiencing a continuous upsurge in demand, primarily propelled by the increasing prevalence of cardiovascular diseases, peripheral vascular diseases, and associated health conditions. These conditions impose a significant economic burden on healthcare systems worldwide, compelling investments and innovations in peripheral interventions to enhance treatment effectiveness.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 10.2 billion |
Market size value in 2032 | USD 22.34 billion |
Growth Rate | 9.1% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Peripheral Interventions Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Peripheral Interventions Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Peripheral Interventions Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Peripheral Interventions Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Peripheral Interventions Market size was valued at USD 9.42 Billion in 2023 and is poised to grow from USD 10.22 Billion in 2024 to USD 19.63 Billion by 2032, growing at a CAGR of 8.50% during the forecast period (2025-2032).
The global peripheral interventions market presents a dynamic competitive scenario, marked by the active participation of numerous prominent companies seeking market leadership. Key industry players, including Johnson & Johnson, Medtronic, Becton Dickinson, and Boston Scientific Corporation, hold pivotal roles in shaping the landscape of this sector. These industry giants capitalize on their extensive expertise, robust research and development capabilities, and global market presence to introduce innovative solutions spanning various segments within peripheral interventions. 'Johnson & Johnson (United States)', 'Medtronic (United States)', 'Becton Dickinson (United States)', 'Boston Scientific Corporation (United States)', 'Abbott Laboratories (United States)', 'Terumo Corporation (Japan)', 'Cook Medical (United States)', 'Cardinal Health (United States)', 'C. R. Bard (United States)', 'Teleflex Incorporated (United States)', 'AngioDynamics Inc. (United States)', 'B. Braun Melsungen AG (Germany)', 'Asahi Intecc Co., Ltd. (Japan)', 'Penumbra, Inc. (United States)', 'Stryker Corporation (United States)', 'Terumo Interventional Systems (United States)', 'Olympus Corporation (Japan)', 'Nipro Corporation (Japan)', 'Endologix Inc. (United States)', 'Merit Medical Systems, Inc. (United States)'
Rising Cardiovascular Disease (CVD) Prevalence The growing prevalence of cardiovascular conditions, which includes peripheral artery disease (PAD), is what's driving the call for peripheral remedies. The rising incidence of CVDs is primarily attributed to hazard elements such hypertension, diabetes, obesity, and a sedentary way of life.
Heterogeneous Catheterization Labs: Invasive interventional treatments such as cardiac, vascular, neurological, and electrophysiological are increasingly being performed in hybrid catheterization labs, which are growing in popularity. The market is growing as a result of these adaptable facilities.
North America has held a dominant role in the marketplace, commonly due to technological improvements, strong scientific repayment facilities, and a growing stage of consciousness of some of the populace in this location. With a rising prevalence of coronary artery sicknesses and a developing prevalence of peripheral vascular illnesses, North America is poised to preserve its marketplace leadership for the duration of the forecast length.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35D2214
[email protected]
USA +1 351-333-4748